U.S. Skin Graft Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
U.S. skin graft market is expected to reach USD 522.52 million by 2025 from USD 293.00 million in 2017, at a CAGR of 7.6% in the forecast period 2018 to 2025.
The major factors driving the growth of this market are increasing number of burns injuries, pressure ulcers and skin infections, developments in skin grafting techniques and technological advances in dermatomes are boosting the growth of the U.S. skin graft market.
The key market players for U.S. skin graft market are listed below:
The U.S. skin graft market is segmented based on type into autologous, allogeneic, xenogeneic, prosthetic and isogeneic. In 2018, autologous is expected to dominate the U.S. skin graft market with 38.5% market share and is expected to reach USD 207.25 million by 2025, growing at the highest CAGR of 8.1% in the forecast period of 2018 to 2025.
The U.S. skin graft market is segmented based on graft thickness into split-thickness, full-thickness, and composite graft. In 2018, split-thickness is expected to dominate the U.S. skin graft market with 47.9% market share and is expected to reach USD 254.38 million by 2025, growing at the highest CAGR of 7.8% in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented based on application into burns, extensive wound, skin cancer, and extensive skin loss due to infection. In 2018, burns is expected to dominate the U.S. skin graft market with 46.7% market share and is expected to reach USD 251.53 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented based on equipment type into dermatome, general surgical instruments, consumables, and others. In 2018, dermatome is expected to dominate the U.S. Skin graft market with 43.7% market share and is expected to reach USD 235.29 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.
Dermatome is further sub-segmented into electrical dermatomes, air-powdered dermatomes, knife dermatomes, and drum dermatomes. In 2018, electrical dermatomes is expected to dominate the U.S. Skin graft market with 47.6% market share and is expected to reach USD 115.88 million by 2025, growing at the highest CAGR of 8.6% in the forecast period 2018 to 2025.
Knife dermatome is further sub-segmented into Watson Knife, Cobbett Knife, and Blair/Brown Knife. In 2018, Watson Knife is expected to dominate the U.S. skin graft market with 53.9% market share and is expected to reach USD 63.51 million by 2025, growing at the highest CAGR of 8.8% in the forecast period 2018 to 2025.
Drum dermatome is further sub-segmented into Padgett Dermatomes, and Reese Dermatomes. In 2018, Padgett Dermatomes is expected to dominate the U.S. skin grafts market with 61.5% market share and is expected to reach USD 317.01 million by 2025, with a CAGR of 7.4% in the forecast period 2018 to 2025. However, Reese Dermatomes is expected to grow at the highest CAGR of 7.9% in the forecast period, to reach USD 205.51 million by 2025 from USD 112.51 million in 2017 in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented on the basis of end users into ambulatory surgical centers, hospitals, and dermatology clinics. In 2018, ambulatory surgical centers is expected to dominate the U.S. skin graft market with 53.2% market share and is expected to reach USD 282.82 million by 2025, growing at the highest CAGR of 7.9% in the forecast period 2018 to 2025.
Covered in this report
The report covers the present scenario and the growth prospects of the U.S. skin graft market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The major factors driving the growth of this market are increasing number of burns injuries, pressure ulcers and skin infections, developments in skin grafting techniques and technological advances in dermatomes are boosting the growth of the U.S. skin graft market.
The key market players for U.S. skin graft market are listed below:
- Integra Lifesciences Corporation
- Organogenesis, Inc.
- Zimmer Biomet, Inc.
- B. Braun Melsungen AG
- Nouvag AG
- DE Soutter Medical Limited
- Surtex Instruments Limited
- Exsurco Medical, Inc.
- Type
- Graft Thickness
- Application
- Equipment Type
- End-user
The U.S. skin graft market is segmented based on type into autologous, allogeneic, xenogeneic, prosthetic and isogeneic. In 2018, autologous is expected to dominate the U.S. skin graft market with 38.5% market share and is expected to reach USD 207.25 million by 2025, growing at the highest CAGR of 8.1% in the forecast period of 2018 to 2025.
The U.S. skin graft market is segmented based on graft thickness into split-thickness, full-thickness, and composite graft. In 2018, split-thickness is expected to dominate the U.S. skin graft market with 47.9% market share and is expected to reach USD 254.38 million by 2025, growing at the highest CAGR of 7.8% in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented based on application into burns, extensive wound, skin cancer, and extensive skin loss due to infection. In 2018, burns is expected to dominate the U.S. skin graft market with 46.7% market share and is expected to reach USD 251.53 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented based on equipment type into dermatome, general surgical instruments, consumables, and others. In 2018, dermatome is expected to dominate the U.S. Skin graft market with 43.7% market share and is expected to reach USD 235.29 million by 2025, growing at the highest CAGR of 8.1% in the forecast period 2018 to 2025.
Dermatome is further sub-segmented into electrical dermatomes, air-powdered dermatomes, knife dermatomes, and drum dermatomes. In 2018, electrical dermatomes is expected to dominate the U.S. Skin graft market with 47.6% market share and is expected to reach USD 115.88 million by 2025, growing at the highest CAGR of 8.6% in the forecast period 2018 to 2025.
Knife dermatome is further sub-segmented into Watson Knife, Cobbett Knife, and Blair/Brown Knife. In 2018, Watson Knife is expected to dominate the U.S. skin graft market with 53.9% market share and is expected to reach USD 63.51 million by 2025, growing at the highest CAGR of 8.8% in the forecast period 2018 to 2025.
Drum dermatome is further sub-segmented into Padgett Dermatomes, and Reese Dermatomes. In 2018, Padgett Dermatomes is expected to dominate the U.S. skin grafts market with 61.5% market share and is expected to reach USD 317.01 million by 2025, with a CAGR of 7.4% in the forecast period 2018 to 2025. However, Reese Dermatomes is expected to grow at the highest CAGR of 7.9% in the forecast period, to reach USD 205.51 million by 2025 from USD 112.51 million in 2017 in the forecast period 2018 to 2025.
The U.S. skin graft market is segmented on the basis of end users into ambulatory surgical centers, hospitals, and dermatology clinics. In 2018, ambulatory surgical centers is expected to dominate the U.S. skin graft market with 53.2% market share and is expected to reach USD 282.82 million by 2025, growing at the highest CAGR of 7.9% in the forecast period 2018 to 2025.
Covered in this report
The report covers the present scenario and the growth prospects of the U.S. skin graft market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
1. INTRODUCTION
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of U.S. Skin Graft Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered
2. MARKET SEGMENTATION
2.1. Markets Covered
2.2. Years Considered For The Study
2.3. Currency And Pricing
2.4. Research Methodology
2.5. Primary Interviews With Key Opinion Leaders
2.6. Secondary Sources
2.7. Assumptions
3. MARKET OVERVIEW
3.1. Drivers
3.1.1. Increasing Number Of Burns Injuries, Pressure Ulcers, And Skin Infections
3.1.2. Technological Advancements And Developments In Skin Grafting Techniques
3.1.3. Favorable Reimbursement Policies For Skin Grafting Procedure
3.2. Restraints
3.2.1. Side Effects Related To The Skin Graft Procedure
3.3. Opportunities
3.3.1. Increasing Medical Tourisms
3.4. Challenges
3.4.1. Competition Among Major Players In The U.S.
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. U.S. SKIN GRAFT MARKET, BY TYPE
6.1. Overview
6.2. Autologous
6.3. Isogeneic
6.4. Allogeneic
6.5. Xenogeneic
6.6. Prosthetic
7. U.S. SKIN GRAFT MARKET, BY GRAFT THICKNESS
7.1. Overview
7.2. Split-Thickness
7.3. Full-Thickness
7.4. Composite Graft
8. U.S. SKIN GRAFT MARKET, BY APPLICATION
8.1. Overview
8.2. Extensive Wound
8.3. Extensive Skin Loss Due To Infection
8.4. Skin Cancer
8.5. Burns
9. U.S. SKIN GRAFT MARKET, BY EQUIPMENT TYPE
9.1. Overview
9.2. Dermatome
9.2.1. Knife Dermatomes
9.2.1.1. Blair/Brown Knife
9.2.1.2. Watson Knife
9.2.1.3. Cobbett Knife
9.2.2. Drum Dermatomes
9.2.2.1. Padgett Dermatomes
9.2.2.2. Reese Dermatomes
9.2.3. Electrical Dermatomes
9.2.4. Air-Powdered Dermatomes
9.3. General Surgical Instruments
9.4. Consumables
9.5. Others
10. U.S. SKIN GRAFT MARKET, BY END USER
10.1. Overview
10.2. Hospitals
10.3. Dermatology Clinics
10.4. Ambulatory Surgical Centers
11. U.S. SKIN GRAFT MARKET, COMPANY LANDSCAPE
11.1. Company Share Analysis: North America
12. COMPANY PROFILES
12.1. Organogenesis Inc.
12.1.1. Company Overview
12.1.2. Organogenesis Inc.: Company Snapshot
12.1.3. Product Portfolio
12.1.4. Recent Developments
12.2. Integra Lifesciences Corporation
12.2.1. Company Overview
12.2.2. Integra Lifesciences Corporation: Revenue Analysis
12.2.3. Product Portfolio
12.2.4. Recent Developments
12.3. Zimmer Biomet
12.3.1. Company Overview
12.3.2. Zimmer Biomet: Revenue Analysis
12.3.3. Product Portfolio
12.3.4. Recent Developments
12.4. B. Braun Melsungen Ag
12.4.1. Company Overview
12.4.2. B. Braun Melsungen Ag: Revenue Analysis
12.4.3. Product Portfolio
12.4.4. Recent Developments
12.5. Avita Medical
12.5.1. Company Overview
12.5.2. Avita Medical:Revenue Analysis
12.5.3. Product Portfolio
12.5.4. Recent Developments
12.6. De Soutter Medical
12.6.1. Company Overview
12.6.2. De Soutter Medical: Company Snapshot
12.6.3. Product Portfolio
12.6.4. Recent Developments
12.7. Exsurco Medical, Inc.
12.7.1. Company Overview
12.7.2. Exsurco Medical, Inc.:Company Snapshot
12.7.3. Product Portfolio
12.7.4. Recent Developments
12.8. Mallinckrodt
12.8.1. Company Overview
12.8.2. Mallinckrodt: Revenue Analysis
12.8.3. Product Pipeline
12.8.4. Recent Developments
12.9. Nouvag
12.9.1. Company Overview
12.9.2. Nouvag: Company Snapshot
12.9.3. Product Portfolio
12.9.4. Recent Developments
12.10. Surtex Instruments Limited
12.10.1. Company Overview
12.10.2. Surtex Instruments Limited: Company Snapshot
12.10.3. Product Portfolio
12.10.4. Recent Developments
12.11. Tissue Regenix
12.11.1. Company Overview
12.11.2. Tissue Regenix: Revenue Analysis
12.11.3. Product Portfolio
12.11.4. Recent Developments
13. RELATED REPORTS
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of U.S. Skin Graft Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered
2. MARKET SEGMENTATION
2.1. Markets Covered
2.2. Years Considered For The Study
2.3. Currency And Pricing
2.4. Research Methodology
2.5. Primary Interviews With Key Opinion Leaders
2.6. Secondary Sources
2.7. Assumptions
3. MARKET OVERVIEW
3.1. Drivers
3.1.1. Increasing Number Of Burns Injuries, Pressure Ulcers, And Skin Infections
3.1.2. Technological Advancements And Developments In Skin Grafting Techniques
3.1.3. Favorable Reimbursement Policies For Skin Grafting Procedure
3.2. Restraints
3.2.1. Side Effects Related To The Skin Graft Procedure
3.3. Opportunities
3.3.1. Increasing Medical Tourisms
3.4. Challenges
3.4.1. Competition Among Major Players In The U.S.
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. U.S. SKIN GRAFT MARKET, BY TYPE
6.1. Overview
6.2. Autologous
6.3. Isogeneic
6.4. Allogeneic
6.5. Xenogeneic
6.6. Prosthetic
7. U.S. SKIN GRAFT MARKET, BY GRAFT THICKNESS
7.1. Overview
7.2. Split-Thickness
7.3. Full-Thickness
7.4. Composite Graft
8. U.S. SKIN GRAFT MARKET, BY APPLICATION
8.1. Overview
8.2. Extensive Wound
8.3. Extensive Skin Loss Due To Infection
8.4. Skin Cancer
8.5. Burns
9. U.S. SKIN GRAFT MARKET, BY EQUIPMENT TYPE
9.1. Overview
9.2. Dermatome
9.2.1. Knife Dermatomes
9.2.1.1. Blair/Brown Knife
9.2.1.2. Watson Knife
9.2.1.3. Cobbett Knife
9.2.2. Drum Dermatomes
9.2.2.1. Padgett Dermatomes
9.2.2.2. Reese Dermatomes
9.2.3. Electrical Dermatomes
9.2.4. Air-Powdered Dermatomes
9.3. General Surgical Instruments
9.4. Consumables
9.5. Others
10. U.S. SKIN GRAFT MARKET, BY END USER
10.1. Overview
10.2. Hospitals
10.3. Dermatology Clinics
10.4. Ambulatory Surgical Centers
11. U.S. SKIN GRAFT MARKET, COMPANY LANDSCAPE
11.1. Company Share Analysis: North America
12. COMPANY PROFILES
12.1. Organogenesis Inc.
12.1.1. Company Overview
12.1.2. Organogenesis Inc.: Company Snapshot
12.1.3. Product Portfolio
12.1.4. Recent Developments
12.2. Integra Lifesciences Corporation
12.2.1. Company Overview
12.2.2. Integra Lifesciences Corporation: Revenue Analysis
12.2.3. Product Portfolio
12.2.4. Recent Developments
12.3. Zimmer Biomet
12.3.1. Company Overview
12.3.2. Zimmer Biomet: Revenue Analysis
12.3.3. Product Portfolio
12.3.4. Recent Developments
12.4. B. Braun Melsungen Ag
12.4.1. Company Overview
12.4.2. B. Braun Melsungen Ag: Revenue Analysis
12.4.3. Product Portfolio
12.4.4. Recent Developments
12.5. Avita Medical
12.5.1. Company Overview
12.5.2. Avita Medical:Revenue Analysis
12.5.3. Product Portfolio
12.5.4. Recent Developments
12.6. De Soutter Medical
12.6.1. Company Overview
12.6.2. De Soutter Medical: Company Snapshot
12.6.3. Product Portfolio
12.6.4. Recent Developments
12.7. Exsurco Medical, Inc.
12.7.1. Company Overview
12.7.2. Exsurco Medical, Inc.:Company Snapshot
12.7.3. Product Portfolio
12.7.4. Recent Developments
12.8. Mallinckrodt
12.8.1. Company Overview
12.8.2. Mallinckrodt: Revenue Analysis
12.8.3. Product Pipeline
12.8.4. Recent Developments
12.9. Nouvag
12.9.1. Company Overview
12.9.2. Nouvag: Company Snapshot
12.9.3. Product Portfolio
12.9.4. Recent Developments
12.10. Surtex Instruments Limited
12.10.1. Company Overview
12.10.2. Surtex Instruments Limited: Company Snapshot
12.10.3. Product Portfolio
12.10.4. Recent Developments
12.11. Tissue Regenix
12.11.1. Company Overview
12.11.2. Tissue Regenix: Revenue Analysis
12.11.3. Product Portfolio
12.11.4. Recent Developments
13. RELATED REPORTS
LIST OF TABLES
Table 1 Few Cpt Codes For Skin Graft Procedures
Table 2 U.S. Skin Graft Market, By Type, 2016 - 2025 (Usd Million)
Table 3 U.S. Skin Graft Market, By Graft Thickness, 2016 - 2025 (Usd Million)
Table 4 U.S. Skin Graft Market, By Application, 2016 - 2025 (Usd Million)
Table 5 U.S. Skin Graft Market, By Equipment Type, 2016 - 2025 (Usd Million)
Table 6 U.S. Dermatome Market, By Equipment Type, 2016 - 2025 (Usd Million)
Table 7 U.S. Knife Dermatomes Market, By Equipment Type, 2016 - 2025 (Usd Million)
Table 8 U.S. Drum Dermatomes Market, By Equipment Type, 2016 - 2025 (Usd Million)
Table 9 U.S. Skin Graft Market, By End User, 2016 - 2025 (Usd Million)
Table 1 Few Cpt Codes For Skin Graft Procedures
Table 2 U.S. Skin Graft Market, By Type, 2016 - 2025 (Usd Million)
Table 3 U.S. Skin Graft Market, By Graft Thickness, 2016 - 2025 (Usd Million)
Table 4 U.S. Skin Graft Market, By Application, 2016 - 2025 (Usd Million)
Table 5 U.S. Skin Graft Market, By Equipment Type, 2016 - 2025 (Usd Million)
Table 6 U.S. Dermatome Market, By Equipment Type, 2016 - 2025 (Usd Million)
Table 7 U.S. Knife Dermatomes Market, By Equipment Type, 2016 - 2025 (Usd Million)
Table 8 U.S. Drum Dermatomes Market, By Equipment Type, 2016 - 2025 (Usd Million)
Table 9 U.S. Skin Graft Market, By End User, 2016 - 2025 (Usd Million)
LIST OF FIGURES
Figure 1 U.S. Skin Graft Market: Segmentation
Figure 2 U.S. Skin Graft Market: Data Triangulation
Figure 3 U.S. Skin Graft Market: Research Snapshot
Figure 4 U.S. Skin Graft Market: Bottom Up Approach
Figure 5 U.S. Skin Graft Market: Top Down Approach
Figure 6 U.S. Skin Graft Market: Interview Demographics
Figure 7 Drivers, Restraints, Opportunities, And Challenges In
U.S. Skin Graft Market
Figure 8 U.S. Skin Graftmarket: Segmentation
Figure 9 Increasing Number Of Burns Injuries, Pressure Ulcers, Skin Infections, And Developments In Skin Grafting Techniques Are Expected To Drive The Market For U.S. Skin Graft In The Forecast Period 2018 To 2025
Figure 10 Autologous Segment Is Expected To Account For The Largest Share Of The U.S. Skin Graft Market In 2018 & 2025
Figure 11 U.S. Skin Graft Market: By Type, 2017
Figure 12 U.S. Skin Graft Market: By Graft Thickness, 2017
Figure 13 U.S. Skin Graft Market: By Application, 2017
Figure 14 U.S. Skin Graft Market: By Equipment Type, 2017
Figure 15 U.S. Skin Graft Market: By End User, 2017
Figure 16 U.S. Skin Graft Market: Company Share 2017 (%)
Figure 1 U.S. Skin Graft Market: Segmentation
Figure 2 U.S. Skin Graft Market: Data Triangulation
Figure 3 U.S. Skin Graft Market: Research Snapshot
Figure 4 U.S. Skin Graft Market: Bottom Up Approach
Figure 5 U.S. Skin Graft Market: Top Down Approach
Figure 6 U.S. Skin Graft Market: Interview Demographics
Figure 7 Drivers, Restraints, Opportunities, And Challenges In
U.S. Skin Graft Market
Figure 8 U.S. Skin Graftmarket: Segmentation
Figure 9 Increasing Number Of Burns Injuries, Pressure Ulcers, Skin Infections, And Developments In Skin Grafting Techniques Are Expected To Drive The Market For U.S. Skin Graft In The Forecast Period 2018 To 2025
Figure 10 Autologous Segment Is Expected To Account For The Largest Share Of The U.S. Skin Graft Market In 2018 & 2025
Figure 11 U.S. Skin Graft Market: By Type, 2017
Figure 12 U.S. Skin Graft Market: By Graft Thickness, 2017
Figure 13 U.S. Skin Graft Market: By Application, 2017
Figure 14 U.S. Skin Graft Market: By Equipment Type, 2017
Figure 15 U.S. Skin Graft Market: By End User, 2017
Figure 16 U.S. Skin Graft Market: Company Share 2017 (%)
